Zenicor Medical Systems operates in the medical technology sector. The company focuses on diagnostics in cardiac healthcare. The technology is based on the company's platform, which is used to identify and diagnose potential atrial fibrillation and cardiac fibrillation disorders. The largest operations are found around the European market. The company was established in 2003 and is headquartered in Stockholm.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Ragnar Winell | 14,98 | 14,98 | 2025-12-23 |
| Christer Jönsson | 9,19 | 9,19 | 2025-12-23 |
| Sonny Norström | 6,44 | 6,44 | 2025-12-23 |
| Mats Palerius | 6,00 | 6,00 | 2025-12-23 |
| Avanza Pension | 4,90 | 4,90 | 2025-12-23 |
| Gundars Rasmanis | 3,91 | 3,91 | 2025-12-23 |
| Bengt Martin Jonsson | 3,58 | 3,58 | 2025-12-23 |
| Försäkringsaktiebolaget Skandia | 3,27 | 3,27 | 2025-12-23 |
| AB Svenska Värden 1915 | 3,02 | 3,02 | 2025-12-23 |
| Sören Mellstig | 2,70 | 2,70 | 2025-12-23 |
2026-04-29 Interim Report 2026-Q1
2026-05-26 Annual General Meeting 2025
2026-07-31 Interim Report 2026-Q2
2026-10-30 Interim Report 2026-Q3
